Advertisement

help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, A.
The Oncologist, Vol. 8, Suppl 1, 10–14, February 2003
© 2003 AlphaMed Press

Treating Fatigue in Cancer Patients

Ann Berger

Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, USA

Correspondence: Ann Berger, R.N., M.S.N., M.D., National Institutes of Health, Clinical Center, Building 10, Room 2N236, 10 Center Drive, Bethesda, Maryland 20892, USA. Telephone: 301-594-9766; Fax: 301-594-9807; e-mail: aberger{at}cc.nih.gov

Possible causes of cancer-related fatigue include depression, pain, sleep problems, anemia, deconditioning, metabolic abnormalities, infection, dietary problems, hypoxia, and side effects of medication. Although treatments are available for each of these conditions, there are no generally accepted treatments available for the whole fatigue syndrome. There are also very few studies on the treatment of cancer-related fatigue—only 10 randomized controlled trials. Health care providers have begun to understand that, just as the treatment of pain requires attention to imbalances in mind, body, and spirit, the treatment of fatigue will require such an approach.

Key Words. Fatigue • Neoplasms • Depression • Anemia • Sleep disorders




This article has been cited by other articles:


Home page
The OncologistHome page
J. K. Carroll, S. Kohli, K. M. Mustian, J. A. Roscoe, and G. R. Morrow
Pharmacologic Treatment of Cancer-Related Fatigue
Oncologist, May 1, 2007; 12(suppl_1): 43 - 51.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
K. M. Mustian, G. R. Morrow, J. K. Carroll, C. D. Figueroa-Moseley, P. Jean-Pierre, and G. C. Williams
Integrative Nonpharmacologic Behavioral Interventions for the Management of Cancer-Related Fatigue
Oncologist, May 1, 2007; 12(suppl_1): 52 - 67.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
A. Sood, D. L. Barton, B. A. Bauer, and C. L. Loprinzi
A Critical Review of Complementary Therapies for Cancer-Related Fatigue
Integr Cancer Ther, March 1, 2007; 6(1): 8 - 13.
[Abstract] [PDF]


Home page
J Oncol Pharm PractHome page
P. Hartvig, J. Aulin, S. Wallenberg, and G. Wagenius
Physical exercise for cytotoxic drug-induced fatigue
Journal of Oncology Pharmacy Practice, December 1, 2006; 12(4): 183 - 191.
[Abstract] [PDF]


Home page
Biol Res NursHome page
L. J. Wood, L. M. Nail, N. A. Perrin, C. R. Elsea, A. Fischer, and B. J. Druker
The Cancer Chemotherapy Drug Etoposide (VP-16) Induces Proinflammatory Cytokine Production and Sickness Behavior-like Symptoms in a Mouse Model of Cancer Chemotherapy-Related Symptoms.
Biol Res Nurs, October 1, 2006; 8(2): 157 - 169.
[Abstract] [PDF]


Home page
The OncologistHome page
P. A. Daly
Introduction: All Ireland Fatigue Coalition
Oncologist, February 1, 2003; 8(90001): 1 - 2.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 2003 by AlphaMed Press.
Advertisement